prikaz prve stranice dokumenta Dyslipidemia: Current Perspectives and Implications for Clinical Practice
  Preuzmi
PDF 310.87 KB
Znanstveni rad - Poglavlje u knjizi
Dyslipidemia: Current Perspectives and Implications for Clinical Practice
U: Management of Dyslipidemia / Aronow, Wilbert S. (ur.). Rijeka: IntechOpen, 2021. str. 148-158. https://doi.org/10.5772/intechopen.87280
Klobučar Majanović, Sanja; Cvijanović Peloza, Olga; Detel, Dijana; Kenđel Jovanović, Gordana; Bakula, Miro; Rahelić, Dario; Čaljkušić-Mance, Tea; Šoić Vranić, Tamara; Zoričić Cvek, Sanja

Institucijski repozitorij: Repozitorij Medicinskog fakulteta u Rijeci

Citirajte ovaj rad

Klobučar Majanović, S., Cvijanović Peloza, O., Detel, D., Kenđel Jovanović, G., Bakula, M., Rahelić, D. ... Zoričić Cvek, S. (2021). Dyslipidemia: Current Perspectives and Implications for Clinical Practice. U W. S. Aronow, (Ur.), Management of Dyslipidemia (str. 148-158). Rijeka: IntechOpen. doi: 10.5772/intechopen.87280

Klobučar Majanović, Sanja, et al. "Dyslipidemia: Current Perspectives and Implications for Clinical Practice." Management of Dyslipidemia, Ur. Wilbert S. Aronow, IntechOpen, 2021, str. 148-158. https://urn.nsk.hr/urn:nbn:hr:184:104768

Klobučar Majanović, Sanja, Olga Cvijanović Peloza, Dijana Detel, Gordana Kenđel Jovanović, Miro Bakula, Dario Rahelić, Tea Čaljkušić Mance, Tamara Šoić Vranić i Sanja Zoričić Cvek. "Dyslipidemia: Current Perspectives and Implications for Clinical Practice." U Management of Dyslipidemia, ur. Wilbert S. Aronow, 148-158. Rijeka: IntechOpen, 2021. https://urn.nsk.hr/urn:nbn:hr:184:104768

Klobučar Majanović, S., et al. (2021) 'Dyslipidemia: Current Perspectives and Implications for Clinical Practice' u Aronow, W. S. (ur.) Management of Dyslipidemia Rijeka: IntechOpen, str. 148-158. Preuzeto s: https://urn.nsk.hr/urn:nbn:hr:184:104768 (Datum pristupa: 25.12.2024.)

Klobučar Majanović S, Cvijanović Peloza O, Detel D, Kenđel Jovanović G, Bakula M, Rahelić D, i sur.. Dyslipidemia: Current Perspectives and Implications for Clinical Practice. U: W. S. Aronow, ur. Management of Dyslipidemia. Rijeka: IntechOpen; 2021. Str. 148-158. [pristupljeno 25.12.2024.] Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:104768

S. Klobučar Majanović, et al., "Dyslipidemia: Current Perspectives and Implications for Clinical Practice", Management of Dyslipidemia, W. S. Aronow, Ur. Rijeka: IntechOpen, 2021, str. 148-158. [Online] Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:104768

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:104768
Podaci o radu
Naslov (engleski)Dyslipidemia: Current Perspectives and Implications for Clinical Practice
AutorSanja Klobučar Majanović
AutorOlga Cvijanović Peloza
AutorDijana Detel
AutorGordana Kenđel Jovanović
AutorMiro Bakula
AutorDario Rahelić
AutorTea Čaljkušić-Mance
AutorTamara Šoić Vranić
AutorSanja Zoričić Cvek
UrednikWilbert S. Aronow
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Dyslipidemia refers to a broad spectrum of various genetic and acquired disorders that affect blood lipid levels and largely contribute to global cardiovascular disease burden. Consistent evidence from epidemiological and clinical studies, supports the key role of the circulating LDL- cholesterol and other apoB containing lipoproteins in atherogenesis. All ApoB-containing lipoproteins with size less than 70 nm can cross the endothelial barrier, particularly in the presence of endothelial dysfunction. Uptake and accumulation of apoB-containing lipoproteins in the arterial wall is a critical initiating event in the development of atherosclerosis. Statin treatment, targeting LDL cholesterol reduction, remains the cornerstone of dyslipidemia management. There are abundant data supporting the concept of ‘the lower LDL-C, the better’ in the primary and secondary cardiovascular disease prevention. This chapter provides an overview of the key insights into the lipid abnormalities associated with an increased risk of CV events particulary in the context of dyslipidemia management in everyday clinical practice. Understanding the important role that metabolic derangements play in the pathogenesis of atherosclerosis pave the way for stronger implementation of current guidelines for CVD risk assessment and prevention.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Poglavlje u knjizi
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov knjigeManagement of Dyslipidemia
Brojčani podacistr. 148-158
ISBN978-1-83968-508-8
DOIhttps://doi.org/10.5772/intechopen.87280
URN:NBNurn:nbn:hr:184:104768
Datum objave publikacije2021
URL dokumentahttp://bib.irb.hr/1163204
Vrsta resursaTekst
IzdavačIntechOpen
Mjesto izdavanjaRijeka
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2022-01-04 13:50:37